The use of growth hormone in the treatment of extensive burns: a case report.

Growth hormone is an anabolic hormone that causes increased cell growth, positive nitrogen and calcium balance, lipolysis, hyperglycemia, and promotes protein synthesis. Its beneficial effect in burn treatment was proven particularly in children, by Herndon's group. The authors report The case of a 12-year-old boy with an electrical arc burn of 81% of the BSA, 60% of the BSA being full thickness loss. Recombinant human growth hormone (Norditropin, Novo Nordisk) was administered at daily doses of 0.52 i.u./kg starting on day 19 post-burn for 15 consecutive days. The treatment was well tolerated except for mild insulinoresistance, which could be easily corrected by slightly increasing the insulin added to glucose solutions. After 56 days of intensive care treatment and several excision and grafting procedures, the majority of burns were healed.

Fluid resuscitation in thermally injured pediatric patients.

More than two-thirds of critical burns in special burn units are children. The burned child continues to represent a special challenge, since resuscitation therapy must be more precise than that for an adult with a similar burn. Children have a limited physiologic reserve and the pediatric fluid replacement therapy is based on the principle of separate calculation of physiological and pathological losses. We have reviewed the most widely accepted pediatric isotonic fluid protocols. All these protocols calculate for replacement of pathological losses with a need of 2 ml/kg/% BSAB (body surface area burn) or 4 ml/kg/% BSAB. We choosed the formulas of two Shriner's Burns Institutes--the Cincinnati and the Galveston Unit as representatives, and calculated the fluid therapy for model burn children weights of 10 kg, 30 kg with 20, 40, 60, 80% BSAB. The results of calculations where compared with physiologic parameters of children. In conclusions we could show, that the 4 ml/kg/% BSAB formulas do replace all theoretically predicted pathophysiologic losses due to burns. However, the 2 ml/kg/% BSAB formulas are more practical as a guideline for resuscitation of pediatric patients because of greater therapeutical range and better clinical response of children threatened by burn shock. It is important to remember that all formulas are only guides to fluid therapy, they should be modified according to individual needs and clinical status of the patient. Only successful restoring and maintaining perfusion pressures leads to optimal oxygenation of injured and noninjured tissues, which promotes spontaneous healing, prevents wound conversion, minimise bacterial colonisation, and prepares the injured areas for early grafting.

Early enteral nutrition in severe burns.

The method of early enteral nutrition (EEN) in extensively burned patients was started at the Bratislava Burns Department in January 1992. EEN was instituted in all patients with burns exceeding 20% of the BSA who were admitted to the department not later than 6 hours post burn. The nutrition itself was started with administration of milk, and later on, if good tolerance was observed, the milk was replaced by standard tube feeding formulas. The feeding was adjusted to the actual needs of the individual patients according to nutritional balance calculations and regular control of the patients' weights. During a period of 18 months 20 patients met the criteria for EEN. Twelve of them survived and 8 died due to complications of extensive burns. The overall tolerance of EEN was very good in both the survivors and nonsurvivors groups of patients. EEN proved to be safe and effective in maintaining nutritional balance of the patients and eliminating particularly the occurrence of Curling's ulcers.